Nanopolystyrene Translocation and Fetal Deposition After Acute Lung Exposure During Late-Stage Pregnancy

doi:10.21203/rs.3.rs-39676/v1

PDF

Research

Nanopolystyrene Translocation and Fetal Deposition After Acute Lung Exposure During Late-Stage Pregnancy

https://doi.org/10.21203/rs.3.rs-39676/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 24 Oct, 2020

Read the published version in Particle and Fibre Toxicology →

You are reading this older preprint version

Read the latest preprint version →

Background: Plastic is everywhere. It is used in food packaging, storage containers, electronics, furniture, clothing, and common single-use disposable items. Microplastic and nanoplastic particulates are formed from bulk fragmentation and disintegration of plastic pollution. Plastic particulates have recently been detected in indoor air and remote atmospheric fallout. Due to their small size, microplastic and nanoplastic particulate in the atmosphere can be inhaled and may pose a risk for human health, specifically in susceptible populations. When inhaled, nanosized particles have been shown to translocate across pulmonary cell barriers to secondary organs, including the placenta. However, the potential for maternal-to-fetal translocation of nanosized-plastic particles and the impact of nanoplastic deposition and accumulation on fetal health remain unknown. In this study we investigated whether nanopolystyrene particles can cross the placental barrier and deposit in fetal tissues after maternal pulmonary exposure.

Results: Pregnant Sprague Dawley rats were exposed to 20 nm rhodamine-labeled nanopolystyrene beads (2.64 x 10¹⁴ particles) via intratracheal instillation on gestational day (GD) 19. Twenty-four hours later on GD 20, maternal and fetal tissues were evaluated using fluorescent optical imaging. Fetal tissues were fixed for particle visualization with hyperspectral microscopy. Using isolated placental perfusion, a known concentration of nanopolystyrene was injected into the uterine artery. Maternal and fetal effluents were collected for 180 minutes and assessed for polystyrene particle concentration. Twenty-four hours after maternal exposure, fetal and placental weights were significantly lower (7% and 8%, respectively) compared with controls. Nanopolystyrene particles were detected in the maternal lung, heart, and spleen. Polystyrene nanoparticles were also observed in the placenta, fetal liver, lungs, heart, kidney, and brain suggesting maternal lung-to-fetal tissue nanoparticle translocation in late stage pregnancy.

Conclusion: These studies confirm that maternal pulmonary exposure to nanopolystyrene results in the translocation of plastic particles to placental and fetal tissues and renders the fetoplacental unit vulnerable to adverse effects. These data are vital to the understanding of plastic particulate toxicology and the developmental origins of health and disease.

Toxicology

nanoplastics

translocation

pregnancy

maternal

fetal

polystyrene

perfusion

Plastics are ubiquitous in modern society, used worldwide in a variety of applications ranging from manufacturing, packaging materials, personal products, and medical devices. Growing production and post-consumer plastic waste disposal contribute to the accumulation of plastic in landfills, waterways, and oceans [1]. In the natural environment, material fragmentation of bulk plastic waste by a combination of physical, chemical, and biological processes produces smaller particles referred to as microplastics (< 5 mm in a single dimension [2]) and nanoplastics (< 100 nm in a single dimension). Recent literature identified microplastics in remote atmospheric fallout [3, 4] and as a significant component of indoor air pollution [3]. These have raised concerns for potential adverse health effects of human nanoplastic particle inhalation [5]. In an occupational setting the potential for unintentional exposure to aerosolized micro- and nanoplastics is a critical issue. According to the National Institute for Occupational Safety and Health (NIOSH) there are presently no occupational exposure limits for micro- or nano-sized plastic particles. Current data on exposure to micro- and nanoplastics in a consumer or occupational context are very limited as the quantification of emissions in a background of ambient air particles cannot be accurately measured with existing technology [6] but may be estimated based on fragmentation of microplastics in the environment. A recent meta-analysis demonstrated that adult women are exposed to an average of 258 microplastic particles per day, of which inhalation accounts for 132 microplastic particles [7].

Compared with like particles of a larger size, nanoparticles have the propensity to access deeper regions of the lung and cross biological barriers [8]. Gold was detected in the blood and urine of healthy volunteers following acute inhalation of engineered gold nanoparticles [9]. Titanium was identified in the spleen and liver of young adult (12–13 weeks) and aged (19 months) rats exposed to a TiO₂ nanostructured aerosol [10]. Similarly, we have reported particle translocation of multi-walled carbon nanotubes (MWCNT) to the heart, kidneys, and other systemic tissues after inhalation of MWCNT aerosols in young adult rats [11]. While investigations of the impact of micro- and nanoplastic pollution in terrestrial ecosystems are limited, numerous studies have documented the effects of micro- and nanoplastics on the aquatic environment [5, 12, 13]. Mattsson et al. reported trophic transfer from prey to predator within a laboratory-simulated food chain where 53 nm polystyrene particles transferred from algae to the zooplankter Daphnia magna, and then to a freshwater fish [14]. Polystyrene nanoparticles were identified in the yolk sac, gastrointestinal tract, liver, and pancreas of F1 embryos and larvae of adult female zebrafish fed polystyrene nanoparticles, providing evidence of maternal-offspring transfer [15]. Microplastic polystyrene particles (20 um) accumulated (size-dependent) in the liver, kidney, and gut of mice exposed via drinking water. Further, investigators identified alterations in biomarkers of oxidative stress, lipid metabolism, and neurotoxicity, suggesting widespread health risks of polystyrene nanoparticle exposure in mice [16]. Cellular uptake of polystyrene nanoparticles (25 nm and 70 nm) has been reported in human alveolar epithelial A549 cells. Nanoplastic exposure reduced cell viability, induced cell cycle S phase arrest, and up-regulation of pro-inflammatory cytokines and pro-apoptotic proteins. Importantly, exposure duration, particle diameter, and concentration were key determinants of the toxicological effects of polystyrene nanoparticle exposure on alveolar epithelial cells [17].

While information about the risk of airborne micro- and nanoplastic particles to human health is limited, recent studies in mammalian models have identified maternal-to-offspring translocation of nanoplastic particles raising concerns for the risk of adverse health effects in dams and embryos/fetuses during pregnancy [18]. Using an ex vivo human placental perfusion model, Wick et al. confirmed size-dependent maternal-to-fetal placental translocation of fluorescent polystyrene particles (50 nm, 80 nm, and 240 nm) [19]. Furthermore, Grafmueller et al. examined the bidirectional transfer of polystyrene particles using the ex vivo human placental perfusion model and observed placental translocation and particle accumulation in the syncytiotrophoblast of the placental tissue [20]. Investigators reported that nanoparticle translocation across the human placenta was dependent on particle physio-chemical characteristics and functionalization and was likely to involve an active, energy-dependent transport pathway [20]. While it is understood that nanoplastic particles are likely to reach the fetal compartment after maternal inhalation, the impact of maternal lung exposure to nanoplastic particles on fetal pup growth and particle deposition within the fetus remains unclear. In this study, we examine the translocation and accumulation/deposition of nanopolystyrene particles in maternal and fetal tissues after a maternal pulmonary exposure in rats during late gestation. Further, we assess the impact of nanopolystyrene particles on fluid flow in real-time across the live placenta using an isolated ex vivo utero-placental perfusion system.

Polystyrene Nanobeads: Stock solutions of commercially available 20 nm rhodamine-labeled polystyrene beads (8.8 × 10¹⁴ particles/mL; PS20-RB-2; NanoCS, New York, NY) were suspended in distilled water and 0.01% surfactant and sonicated for 15 minutes prior to measurement. The size of the nanoparticles was measured with Non-Invasive Backscatter optics (NIBS) using a 4 mW, 633 nm laser. The ENM ζ-potential was also measured via Zetasizer Nano ZS. Independent verification of particle size revealed an average particle agglomerate size of 21.86 nm ± 0.026 and a zeta potential of -0.0874 ± 0.195.

Animals: Time-pregnant Sprague Dawley rats were ordered from Charles River Laboratories (Kingston, NY). Animals were delivered on gestational day (GD) 15 and allowed to acclimate within an AAALAC accredited vivarium at Rutgers University for at least 72 hours. Animals had access to food and water ad libitum. All procedures were approved by the Institutional Animal Care and Use Committee of Rutgers University.

Exposure: Rhodamine-labeled nanopolystyrene particles were prepared by vortexing 300 µl of manufacturer’s 1.0% aqueous suspension for 2 minutes, followed by ultra-sonication on ice, for 5 minutes as previously described [21, 22]. Rats were anesthetized with isoflurane gas (5.0% induction). Animals were placed on an angled board by suspending the upper incisor teeth on an incisor loop at a 45° angle. The tongue was retracted using forceps and a cotton-tipped applicator. Using a veterinary operating otoscope fitted with a speculum, the epiglottis was visualized, and a 20 gauge, 4-inch stainless steel ball-tipped oral gavage needle was inserted via the mouth to the trachea. The rats received intratracheal instillation of 300 µL (2.64 × 10¹⁴ particles) of nanopolystyrene suspension or vehicle (0.9% NaCl). Rats were monitored after instillation until they regained consciousness and normal physiological activity (e.g., walking, eating, drinking, grooming, and resting).

To extrapolate nanopolystyrene particle dosage, we considered an average 1 mm³ atmospheric microparticle and mathematically converted this to nanosized particles representative of our spherical 20 nm polystyrene beads. Therefore, a single microparticle represents 2.39 × 10¹⁴ nanopolystyrene particles (Fig. 1a). Cox et al. reported that the average women inhales 132 microplastic particles per day [7]. Given that maternal minute ventilation, or the volume of gas inhaled during pregnancy, increases by up to 48% while the respiration rate remains unchanged [23], it is likely that daily total exposure is closer to the upper bound of 279 microplastics identified in the study [7]. These data suggest that the average pregnant woman could be exposed to 6.67 × 10¹⁶ nanoplastic particles per day (Fig. 1b). When the surface area of the lung between human (62.7 m²) and our laboratory rat (0.409 m²) model [24] is considered, the appropriate experimental exposure amounts to 4.34 × 10¹⁴ nanoplastic particles (Fig. 1c). This value is much greater than the exposure dose of 2.64 × 10¹⁴ nanoplastic particles and therefore, the exposure dose used in this study is within real-world considerations.

Fluorescent Optical Imaging: Twenty-four hours after exposure, dams were fully anesthetized with 3–5% isoflurane in oxygen and Nair was applied to the abdominal region to remove hair prior to imaging. The animal was transferred into the Bruker In-Vivo Multispectral (MS) FX PRO Imager (Bruker, Billerica, MA, USA) imaging chamber with nose cone attached to the manifold and placed in the prone position. The MSFX Pro Bruker detects bioluminescence, fluorescence, radio isotope, and X-ray.

A brightfield was taken to confirm positioning and provide a snapshot/photo of the scan. The primary scans consisted of an excitation of 480 nm with an emission of 535 nm for a 1-minute exposure. Later scans consisted of an excitation of 550 nm with an emission of 600 nm. For these scans, the detectable light refracting off the contrast was recorded. The final scan in this series was an X-ray of the sample that assisted with co-registration of the signal with organ tissues. Following live imaging, animals were sacrificed by removal of the heart according to the Rutgers IACUC approval. Maternal tissues, fetal pups, and fetal tissues were harvested and placed on a polycarbonate tray. After tissue scans were complete, the regions of interest were measured using Bruker MSFX PRO Image software.

Hyperspectral-enhanced darkfield microscopy: Formalin fixed fetal tissues were processed, embedded in paraffin, and sectioned to 4 microns. Slides were visualized via transmitted darkfield hyperspectral images and data captured using CytoViva optics at 60x magnification with oil objective. Dual Mode Fluorescence (DMF) and full fluorescence images were captured with Texas Red excitation filter and triple pass emission filter for further particle confirmation. Data was processed using ENVI 4.8 (CytoViva, Inc., Auburn, AL).

Placental Isolation and Perfusion: A separate cohort of naïve gravid rats were anesthetized with isoflurane (5% induction and 3% maintenance) on GD 20. The right uterine horn was isolated, removed, and placed into a dish of cold (4 °C) physiological salt solution (PSS). Briefly, the uterine horn was dissected, placental unit was identified, amniotic sac opened, fetal pup removed, and umbilical vessels were ligated and unraveled as previously described [25, 26]. The placental unit was removed and placed into a modified isolated vessel chamber (Living Systems Instrumentation, Burlington, VT) filled with warmed (37 °C), oxygenated (21% O₂ – 5% CO₂ – 74% N₂), circulating PSS. The placental vasculature (uterine artery and umbilical artery and vein) were secured to glass pipettes or 26 gauge, 4-inch stainless steel blunt needles, respectively. The uterine artery was perfused with a peristaltic pump at 80 mmHg and the umbilical artery was perfused at 50 mmHg. After a 30-minute equilibration and 10-minute baseline, a bolus of 900 µL (7.92 × 10¹⁴ particles/mL) of nanopolystyrene particles were slowly injected into the uterine artery. Effluents were collected and weighed from the distal uterine artery and umbilical vein cannula at 10-minute intervals for a total of 180 minutes. The remaining fluid within the stainless-steel needle cannulating the umbilical vein was collected.

Quantification of Nanopolystyrene particles: 25 µL of effluent from each sampling time point was pipetted in duplicate on a 96-well clear bottom plate. Positive control was identified as 25 µL of stock solution and negative control as PSS only. All samples were diluted by adding 100 µL of PSS into each well. Fluorescence was measured by a spectrophotometer at 546/575 nm (excitation/emission) using a SpectraMax M3 fluorescent microplate reader (Molecular Devices, Sunnyvale, CA). Data were collected using SoftMax Pro 6.3 software.

To confirm that the rhodamine tag remained attached to the polystyrene beads throughout the perfusion, maternal and fetal effluents were pooled together for 4 representative experiments. The samples were centrifuged at 100,000 x g for 1 hour in an ultracentrifuge (Beckman Coulter Max-XP tabletop Ultracentrifuge) to pellet polystyrene ENM. 25 µL of supernatant was removed from each sample and placed in a 96-well clear bottom plate and read at 546/575 nm (excitation/emission) using a SpectraMax M3 fluorescent microplate reader (Molecular Devices, Sunnyvale, CA). Data were collected using SoftMax Pro 6.3 software.

Histology: Representative placentas from the perfusion experiments were fixed in 10% neutral buffered formalin, processed and sectioned to 4 µm. Hematoxylin and eosin (H&E) stained slides were assessed by an ACVP board-certified veterinary pathologist.

Statistics: Outliers were identified as above or below 2 standard deviations from the mean and removed. All data were analyzed by Student’s T-test. Statistical significance was set to p < 0.05 and is indicated with an asterisk (*). Trends were identified as p < 0.10 and are indicated with a (T).

Litter Characteristics

Maternal and fetal parameters including maternal weight, litter size, fetal pup weight, placental weight, placental efficiency, and sites of resorption are reported in Table 1. In treated dams, fetal pup and placenta weights were significantly lower in the exposed group compared with control. Resorption sites in the exposed group were also significantly greater compared with control. There were fewer fetal pups in dams treated with nanopolystyrene particles, however, this difference did not reach significance in our cohort.

Table 1

Effect of maternal nanopolystyrene pulmonary exposure on litter characteristics. Values are shown as mean ± SEM. n number of dams. Statistics were analyzed with a one-way analysis of variance (*p ≤ 0.05; T ≤ 0.10).
Treatment	n	Maternal Weight (g)	Number of Fetal Pups	Fetal Pup Weight (g)	Placental Weight (g)	Placental Efficiency	Number of Resorption Sites
Saline	12	353 ± 11	13.3 ± 0.3	2.71 ± 0.05	0.47 ± 0.01	5.79 ± 0.15	0.42 ± 0.14
PS	11	362 ± 17	12.4 ± 0.6	*2.52 ± 0.06	*0.43 ± 0.01	6.08 ± 0.26	*1.13 ± 0.30

Fluorescent Optical Imaging

Primary whole animal scan yielded null results as the skin was too dense to visualize any fluorescence (data not shown). Representative images obtained from secondary scans of maternal and fetal tissues and recorded at the same intensity are given in Fig. 2a and Fig. 2b, respectively. Graphical representations of optical intensities are represented for maternal tissues in Fig. 2c and fetal tissues in Fig. 2d. These data indicate significate nanopolystyrene deposition in the maternal lung, heart, spleen, and a trend toward significance in the gravid uterus. Deposition of polystyrene was elevated in all fetal tissues evaluated. These were significantly higher in the isolated GD 20 fetal pup, fetal abdomen, and isolated liver. There was an elevated trend in the fetal pup and placenta in its entirety within the amniotic sac, isolated placenta, and isolated fetal hearts. These studies indicate nanopolystyrene particle translocation from the maternal lungs to systemic tissues, including the fetus and fetal organs.

Hyperspectral Darkfield Microscopy

Enhanced darkfield imaging of fetal tissue sections readily demonstrated polystyrene nanoparticle deposition, illustrated in Fig. 3. Polystyrene nanoparticles were visualized in the fetal liver, lung, kidney, heart, and brain. In representative images, these particles appear as white dots/spots. These studies further demonstrate nanoplastic particle deposition within fetal tissues.

Placental Perfusion

Polystyrene nanoparticle transfer through the maternal vasculature from the proximal to the distal uterine artery was confirmed within 10 minutes of bolus infusion (Fig. 4a). Nanoparticle transfer across the maternal uterine artery peaked at 20 minutes, remained significantly above baseline for 50 minutes, and was elevated at 90 minutes. Effluent fluorescence returned to normal levels after 100 minutes. Further, elevated concentrations of polystyrene nanoparticles were detected in umbilical effluent within 90 minutes of uterine artery bolus infusion (Fig. 4b). Concentration of the nanoparticles in the umbilical effluent were significantly high after 150 minutes through 180 minutes after infusion and significant concentrations remained in the umbilical cannula after 180 minutes of perfusion. These results confirm the capacity of 20 nm nanopolystyrene plastic particles to pass from the maternal to the fetal compartment within 90-minutes of uterine artery infusion. Interestingly, while fluid flow from the maternal to fetal compartment decreased after both saline control and nanopolystyrene injection, there were no significant differences in fluid flow between groups during the 180-minute perfusion (Fig. 4c). This suggests no reduction in blood flow through the placenta within 180-minutes of particles reaching the uterine artery. Placenta were evaluated after perfusion and no histopathological alterations were identified.

In this study we observed reduced fetal pup weight and reduced placental weight 24 hours after maternal nanopolystyrene particle pulmonary exposure. We also identified nanopolystyrene translocation from the maternal lungs, across the placenta, to the fetal compartment. Deposition of nanoplastic particles was observed in the fetal liver, lung, heart, and brain in late-stage pregnancy. Further, we observed the transfer of nanopolystyrene particles from the maternal uterine circulation, across the placenta to the fetal circulation within 90 minutes without compromising fluid dynamics, using an ex vivo placental perfusion system.

The results of this study corroborate data from previous investigations from our group that have shown reduced fetal weight after chronic maternal inhalation of nano-sized particles [27]. We postulate that reductions in fetal development, as reported here and in previous studies, are associated with indirect vascular deficiencies leading to ischemia and reduced nutrient/waste exchange in late-stages of pregnancy [27, 28, 29]. Nanoplastic particle deposition within the placental vasculature could result in a reduction in blood flow through the placenta due to a physical blockage; however, we did not observe a reduction in fluid flow to the fetal compartment after direct infusion of nanopolystyrene particles into the uterine artery. We have observed decreased fluid flow during ex vivo placental perfusion previously after gold nanoparticle infusion [25]. Future studies to assess the impact of a chronic exposure to nanoplastic particles on fetal growth and development are required for a comprehensive understanding of the health hazards associated with airborne nanoplastics.

Similarly, Grafmueller et al. demonstrated the placental transfer of fluorescently-labeled nanopolystyrene particles from the maternal to the fetal compartment [19, 20]. Upon further study utilizing the ex vivo human placental perfusion model, the authors identified a bidirectional, size-dependent transfer of nanopolystyrene beads without cytotoxicity [20]. While it is recognized that the concentration of particles that translocate from the primary site of exposure to the fetal compartment and tissues is low [30] and that this methodology is not without limitation [31]; it is likely that nanoplastic particle transfer across the placenta involves energy-dependent uptake, material transfer, and particle efflux to the fetal side [20]. As it pertains to nanoplastic particle deposition within the tissues, it remains unclear if the nanopolystyrene particles have been taken up by the fetal cells, if they remain in the vasculature, migrate to the interstitial space, or if they are returned to the maternal circulation in bulk. The uptake and passage of nanosized materials is highly dependent on the physio-chemical properties of the particles including size, functionalization, chemical construct, and surface charge [5].

Furthermore, cellular uptake and subsequent toxicity of nanoplastic particles is dependent on the unique protein and chemical corona that forms on the surface during contact with biological fluids (e.g. pulmonary surfactant, interstitial fluid, plasma) and environmental chemicals; in the case of plastics these chemicals may be adsorbed and serve and a vehicle for chemical transport. Chemical additives adsorbed to the surface or added to plastics during the polymerization process can leach or be transferred from polystyrene products with normal use. These additives may include carcinogens or endocrine disrupting factors (e.g., vinyl chloride, phthalates) [32, 33]. Historical studies identify and refer to the potential for chemical leakage from polystyrene products after the addition of hot, cold, or boiling water [34]. Withey also reported elevated blood styrene in rats after exposures to vapor-phase and intragastric styrene [34]. Together, these outcomes indicate the likelihood of chemical release from particles within an organism. Fetal nanoplastic deposition could lead to life-long localized low-level exposure to these additives or adsorbed chemicals. Future studies are planned to examine chemical release from plastic nanomaterials within a biological environment.

In this study, we identified nanopolystyrene translocation from the maternal lungs to the fetal compartment and deposition in the fetal lungs, liver, heart, kidney, and brain within 24 hours of maternal exposure. It is likely that these particles would remain in the fetus after birth. Endothelial cell exposure to engineered nanomaterials enhances endothelial barrier permeability [35, 36, 37], which offers accessibility to the interstitial space between cells within systemic tissues. Reports pertaining to the development and function of the blood brain barrier in a fetus are inconclusive [38, 39]. Therefore, the blood-brain barrier may not yet be fully formed, rendering the fetal brain susceptible to particle sedimentation. We, and others, have identified that maternal exposures to ENM during gestation can initiate developmental onset of disease within the maturing fetus. In laboratory studies, young and adult offspring have been reported to exhibit coronary dysfunction [40, 41, 42, 43, 44, 45], vascular perturbations [27, 45], reproductive consequences [46, 47, 48, 49, 50], and neurodevelopmental delays [51, 52] after maternal inhalation of engineered nanomaterials during pregnancy. Therefore, particle deposition, and likely particle accumulation and retention, impact offspring health after birth and into adulthood.

Plastic particles are so prevalent in the natural environment that human exposure to microplastics is inevitable. The majority of plastic materials produced end up in landfills [1] and have been estimated to take hundreds of years to breakdown from a larger size through mechanical, ultraviolet, and frictional forces to smaller microplastics and nanosized plastic particles [53]. These particles can enter water and food sources, as identified in tap water, bottled water, and beer [54, 55], become airborne as a constituent of indoor air particulate [56], be identified in planting soils and root structures [57], or contribute to environmental contamination by atmospheric fallout [3, 4, 7].

Collectively, these results identified the impact of a pulmonary exposure to an environmentally relevant dose of nanopolystyrene and examined maternal and fetal parameters and the translocation of plastic particles to, and deposition within fetal tissues. These data are vital to the understanding of plastic particulate toxicology and the developmental onset of health and disease. Future studies are required to provide a more detailed exploration of organ-specific toxicity and the implications of nanoplastic exposure on reproductive potential and fetal development.

ACKNOWLEDGEMENTS

Not Applicable.

FUNDING

This work was supported by the National Institute of Environmental Health Sciences (R00-ES024783), Rutgers Center for Environmental Exposures and Disease (P30-ES005022), and Rutgers Joint Graduate Program in Toxicology (T32-ES007148).

CONTRIBUTIONS

SF conducted the animal exposures, dissections, and was a major contributor in data analysis and writing the manuscript. JD conducted the animal exposures, placental perfusion experiments, and was a major contributor in data analysis and writing the manuscript. DS conducted the optical imaging studies and was a major contributor in data analysis. SK completed the nanoparticle characterizations. MG completed the histological reviews. LF completed the nanoparticle characterizations. EY contributed to data analysis of the optical imaging studies. PS developed the experimental design, oversaw the exposures and experiments, and was a major contributor to the data analysis and writing the manuscript. All authors read and approved the final manuscript.

ETHICS DECLARATIONS

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

All animal experiments were approved by the Institutional Animal Care and Use Committee of Rutgers University.

CONSENT FOR PUBLICATION

Not Applicable.

COMPETING INTERESTS

The authors declare that they have no competing interests.

AVAILABILITY OF DATA AND MATERIALS

All data generated or analysed during this study are included in this published article.

Geyer R, Jambeck JR, Law KL. Production, use, and fate of all plastics ever made. Science advances. 2017;3 7:e1700782; doi: 10.1126/sciadv.1700782.
Wagner M, Engwall M, Hollert H. Editorial: (Micro)Plastics and the environment. Environ Sci Eur. 2014;26 1:16; doi: 10.1186/s12302-014-0016-3. https://www.ncbi.nlm.nih.gov/pubmed/27752414.
Prata JC. Airborne microplastics: Consequences to human health? Environ Pollut. 2018;234:115-26; doi: 10.1016/j.envpol.2017.11.043.
Allen S, Allen D, Phoenix VR, Le Roux G, Durántez Jiménez P, Simonneau A, et al. Atmospheric transport and deposition of microplastics in a remote mountain catchment. Nature Geoscience. 2019;12 5:339-44; doi: 10.1038/s41561-019-0335-5. https://doi.org/10.1038/s41561-019-0335-5.
Stapleton PA. Toxicological considerations of nano-sized plastics. AIMS Environ Sci. 2019;6 5:367-78; doi: 10.3934/environsci.2019.5.367.
Wagner S, Reemtsma T. Things we know and don't know about nanoplastic in the environment. Nature nanotechnology. 2019;14 4:300-1; doi: 10.1038/s41565-019-0424-z.
Cox KD, Covernton GA, Davies HL, Dower JF, Juanes F, Dudas SE. Human Consumption of Microplastics. Environmental science & technology. 2019;53 12:7068-74; doi: 10.1021/acs.est.9b01517.
Stapleton PA, Minarchick VC, McCawley M, Knuckles TL, Nurkiewicz TR. Xenobiotic particle exposure and microvascular endpoints: a call to arms. Microcirculation. 2012;19 2:126-42. http://www.ncbi.nlm.nih.gov/pubmed/21951337.
Miller MR, Raftis JB, Langrish JP, McLean SG, Samutrtai P, Connell SP, et al. Inhaled Nanoparticles Accumulate at Sites of Vascular Disease. ACS Nano. 2017;11 5:4542-52; doi: 10.1021/acsnano.6b08551.
Gate L, Disdier C, Cosnier F, Gagnaire F, Devoy J, Saba W, et al. Biopersistence and translocation to extrapulmonary organs of titanium dioxide nanoparticles after subacute inhalation exposure to aerosol in adult and elderly rats. Toxicol Lett. 2017;265:61-9; doi: 10.1016/j.toxlet.2016.11.009. https://www.ncbi.nlm.nih.gov/pubmed/27865850.
Stapleton PA, Minarchick VC, Cumpston AM, McKinney W, Chen BT, Sager TM, et al. Impairment of coronary arteriolar endothelium-dependent dilation after multi-walled carbon nanotube inhalation: a time-course study. Int J Mol Sci. 2012;13 11:13781-803; doi: 10.3390/ijms131113781. http://www.ncbi.nlm.nih.gov/pubmed/23203034.
Toussaint B, Raffael B, Angers-Loustau A, Gilliland D, Kestens V, Petrillo M, et al. Review of micro- and nanoplastic contamination in the food chain. Food additives & contaminants Part A, Chemistry, analysis, control, exposure & risk assessment. 2019;36 5:639-73; doi: 10.1080/19440049.2019.1583381.
Browne MA, Dissanayake A, Galloway TS, Lowe DM, Thompson RC. Ingested microscopic plastic translocates to the circulatory system of the mussel, Mytilus edulis (L). Environmental science & technology. 2008;42 13:5026-31; doi: 10.1021/es800249a. https://www.ncbi.nlm.nih.gov/pubmed/18678044.
Mattsson K, Ekvall MT, Hansson LA, Linse S, Malmendal A, Cedervall T. Altered behavior, physiology, and metabolism in fish exposed to polystyrene nanoparticles. Environ Sci Technol. 2015;49 1:553-61; doi: 10.1021/es5053655. https://www.ncbi.nlm.nih.gov/pubmed/25380515.
Pitt JA, Trevisan R, Massarsky A, Kozal JS, Levin ED, Di Giulio RT. Maternal transfer of nanoplastics to offspring in zebrafish (Danio rerio): A case study with nanopolystyrene. Sci Total Environ. 2018;643:324-34; doi: 10.1016/j.scitotenv.2018.06.186. https://www.ncbi.nlm.nih.gov/pubmed/29940444.
Deng Y, Zhang Y, Lemos B, Ren H. Tissue accumulation of microplastics in mice and biomarker responses suggest widespread health risks of exposure. Sci Rep. 2017;7:46687; doi: 10.1038/srep46687. https://www.ncbi.nlm.nih.gov/pubmed/28436478.
Xu M, Halimu G, Zhang Q, Song Y, Fu X, Li Y, et al. Internalization and toxicity: A preliminary study of effects of nanoplastic particles on human lung epithelial cell. Sci Total Environ. 2019;694:133794; doi: 10.1016/j.scitotenv.2019.133794. https://www.ncbi.nlm.nih.gov/pubmed/31756791.
Campagnolo L, Massimiani M, Vecchione L, Piccirilli D, Toschi N, Magrini A, et al. Silver nanoparticles inhaled during pregnancy reach and affect the placenta and the foetus. Nanotoxicology. 2017;11 5:687-98; doi: 10.1080/17435390.2017.1343875. https://www.ncbi.nlm.nih.gov/pubmed/28618895.
Wick P, Malek A, Manser P, Meili D, Maeder-Althaus X, Diener L, et al. Barrier capacity of human placenta for nanosized materials. Environ Health Perspect. 2010;118 3:432-6; doi: 10.1289/ehp.0901200. https://www.ncbi.nlm.nih.gov/pubmed/20064770.
Grafmueller S, Manser P, Diener L, Diener PA, Maeder-Althaus X, Maurizi L, et al. Bidirectional Transfer Study of Polystyrene Nanoparticles across the Placental Barrier in an ex Vivo Human Placental Perfusion Model. Environ Health Perspect. 2015;123 12:1280-6; doi: 10.1289/ehp.1409271. https://www.ncbi.nlm.nih.gov/pubmed/25956008.
Minarchick VC, Stapleton PA, Porter DW, Wolfarth MG, Ciftyurek E, Barger M, et al. Pulmonary cerium dioxide nanoparticle exposure differentially impairs coronary and mesenteric arteriolar reactivity. Cardiovasc Toxicol. 2013. http://www.ncbi.nlm.nih.gov/pubmed/23645470.
Minarchick VC, Stapleton PA, Sabolsky EM, Nurkiewicz TR. Cerium dioxide nanoparticle exposure improves microvascular dysfunction and reduces oxidative stress in spontaneously hypertensive rats. Front Physiol. 2015;6:339; doi: 10.3389/fphys.2015.00339. https://www.ncbi.nlm.nih.gov/pubmed/26635625.
LoMauro A, Aliverti A. Respiratory physiology of pregnancy: Physiology masterclass. Breathe (Sheff). 2015;11 4:297-301; doi: 10.1183/20734735.008615. https://www.ncbi.nlm.nih.gov/pubmed/27066123.
Ji JY, J. Estimation of human equivalent exposure from rat inhalation toxicity study of silver nanoparticles using multi-path particle dosimetry model. Toxicological Research. 2012; 1:206-10; doi: 10.1039/c2tx20029e
D'Errico JN, Doherty C, Fournier SB, Renkel N, Kallontzi S, Goedken M, et al. Identification and quantification of gold engineered nanomaterials and impaired fluid transfer across the rat placenta via ex vivo perfusion. Biomed Pharmacother. 2019;117:109148; doi: 10.1016/j.biopha.2019.109148. https://www.ncbi.nlm.nih.gov/pubmed/31347503.
D’Errico JN, Fournier SB, Stapleton PA. Ex vivo perfusion of the rodent placenta. J Vis Exp. 2019; 147:e59412; doi: 10.3791/59412.
Stapleton PA, Minarchick VC, Yi J, Engels K, McBride CR, Nurkiewicz TR. Maternal engineered nanomaterial exposure and fetal microvascular function: does the Barker hypothesis apply? Am J Obstet Gynecol. 2013;209 3:227 e1-11; doi: 10.1016/j.ajog.2013.04.036. http://www.ncbi.nlm.nih.gov/pubmed/23643573.
Fournier SB, Kallontzi S, Fabris L, Love C, Stapleton PA. Effect of gestational age on maternofetal vascular function following single maternal engineered nanoparticle exposure. Cardiovasc Toxicol. 2019; doi: 10.1007/s12012-019-09505-0. https://www.ncbi.nlm.nih.gov/pubmed/30734150.
Stapleton PA, McBride CR, Yi J, Abukabda AB, Nurkiewicz TR. Estrous cycle-dependent modulation of in vivo microvascular dysfunction after nanomaterial inhalation. Reprod Toxicol. 2018;78:20-8; doi: 10.1016/j.reprotox.2018.03.001. https://www.ncbi.nlm.nih.gov/pubmed/29545171.
Hougaard KS, Campagnolo L, Chavatte-Palmer P, Tarrade A, Rousseau-Ralliard D, Valentino S, et al. A perspective on the developmental toxicity of inhaled nanoparticles. Reprod Toxicol. 2015;56:118-40; doi: 10.1016/j.reprotox.2015.05.015. https://www.ncbi.nlm.nih.gov/pubmed/26050605.
Grafmueller S, Manser P, Diener L, Maurizi L, Diener PA, Hofmann H, et al. Transfer studies of polystyrene nanoparticles in the ex vivo human placenta perfusion model: key sources of artifacts. Sci Technol Adv Mater. 2015;16 4:044602; doi: 10.1088/1468-6996/16/4/044602. https://www.ncbi.nlm.nih.gov/pubmed/27877820.
Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonyl-phenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect. 1991;92:167-73; doi: 10.1289/ehp.9192167.
Kik K, Bukowska B, Sicinska P. Polystyrene nanoparticles: Sources, occurrence in the environment, distribution in tissues, accumulation and toxicity to various organisms. Environ Pollut. 2020;262:114297; doi: 10.1016/j.envpol.2020.114297. https://www.ncbi.nlm.nih.gov/pubmed/32155552.
Withey JR. Quantitative analysis of styrene monomer in polystyrene and foods including some preliminary studies of the uptake and pharmacodynamics of the monomer in rats. Environ Health Perspect. 1976;17:125-33; doi: 10.1289/ehp.7617125.
Tee JK, Yip LX, Tan ES, Santitewagun S, Prasath A, Ke PC, et al. Nanoparticles' interactions with vasculature in diseases. Chemical Society reviews. 2019;48 21:5381-407; doi: 10.1039/c9cs00309f.
Setyawati MI, Tay CY, Bay BH, Leong DT. Gold Nanoparticles Induced Endothelial Leakiness Depends on Particle Size and Endothelial Cell Origin. ACS Nano. 2017;11 5:5020-30; doi: 10.1021/acsnano.7b01744.
Tay CY, Setyawati MI, Leong DT. Nanoparticle Density: A Critical Biophysical Regulator of Endothelial Permeability. ACS Nano. 2017;11 3:2764-72; doi: 10.1021/acsnano.6b07806.
Saunders NR, Liddelow SA, Dziegielewska KM. Barrier mechanisms in the developing brain. Front Pharmacol. 2012;3:46; doi: 10.3389/fphar.2012.00046.
Engelhardt B. Development of the blood-brain barrier. Cell and tissue research. 2003;314 1:119-29; doi: 10.1007/s00441-003-0751-z.
Kunovac A, Hathaway QA, Pinti MV, Goldsmith WT, Durr AJ, Fink GK, et al. ROS promote epigenetic remodeling and cardiac dysfunction in offspring following maternal engineered nanomaterial (ENM) exposure. Part Fibre Toxicol. 2019;16 1:24; doi: 10.1186/s12989-019-0310-8. https://www.ncbi.nlm.nih.gov/pubmed/31215478.
Hathaway QA, Durr AJ, Shepherd DL, Pinti MV, Brandebura AN, Nichols CE, et al. miRNA-378a as a key regulator of cardiovascular health following engineered nanomaterial inhalation exposure. Nanotoxicology. 2019;13 5:644-63; doi: 10.1080/17435390.2019.1570372. https://www.ncbi.nlm.nih.gov/pubmed/30704319.
Nichols CE, Shepherd DL, Hathaway QA, Durr AJ, Thapa D, Abukabda A, et al. Reactive oxygen species damage drives cardiac and mitochondrial dysfunction following acute nano-titanium dioxide inhalation exposure. Nanotoxicology. 2018;12 1:32-48; doi: 10.1080/17435390.2017.1416202. https://www.ncbi.nlm.nih.gov/pubmed/29243970.
Stapleton PA, Hathaway QA, Nichols CE, Abukabda AB, Pinti MV, Shepherd DL, et al. Maternal engineered nanomaterial inhalation during gestation alters the fetal transcriptome. Part Fibre Toxicol. 2018;15 1:3; doi: 10.1186/s12989-017-0239-8. http://www.ncbi.nlm.nih.gov/pubmed/29321036.
Hathaway QA, Nichols CE, Shepherd DL, Stapleton PA, McLaughlin SL, Stricker JC, et al. Maternal-engineered nanomaterial exposure disrupts progeny cardiac function and bioenergetics. Am J Physiol Heart Circ Physiol. 2017;312 3:H446-H58; doi: 10.1152/ajpheart.00634.2016. https://www.ncbi.nlm.nih.gov/pubmed/28011589.
Stapleton PA, Nichols CE, Yi J, McBride CR, Minarchick VC, Shepherd DL, et al. Microvascular and mitochondrial dysfunction in the female F1 generation after gestational TiO2 nanoparticle exposure. Nanotoxicology. 2015;9 8:941-51. http://www.ncbi.nlm.nih.gov/pubmed/25475392.
Johansson HKL, Hansen JS, Elfving B, Lund SP, Kyjovska ZO, Loft S, et al. Airway exposure to multi-walled carbon nanotubes disrupts the female reproductive cycle without affecting pregnancy outcomes in mice. Part Fibre Toxicol. 2017;14 1:17; doi: 10.1186/s12989-017-0197-1. https://www.ncbi.nlm.nih.gov/pubmed/28558787
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450058/pdf/12989_2017_Article_197.pdf.
Boisen AM, Shipley T, Jackson P, Wallin H, Nellemann C, Vogel U, et al. In utero exposure to nanosized carbon black (Printex90) does not induce tandem repeat mutations in female murine germ cells. Reprod Toxicol. 2013;41:45-8; doi: 10.1016/j.reprotox.2013.06.068. https://www.ncbi.nlm.nih.gov/pubmed/23871697.
Hougaard KS, Jackson P, Kyjovska ZO, Birkedal RK, De Temmerman PJ, Brunelli A, et al. Effects of lung exposure to carbon nanotubes on female fertility and pregnancy. A study in mice. Reprod Toxicol. 2013;41:86-97; doi: 10.1016/j.reprotox.2013.05.006. https://www.ncbi.nlm.nih.gov/pubmed/23714338.
Kyjovska ZO, Boisen AM, Jackson P, Wallin H, Vogel U, Hougaard KS. Daily sperm production: application in studies of prenatal exposure to nanoparticles in mice. Reprod Toxicol. 2013;36:88-97; doi: 10.1016/j.reprotox.2012.12.005. https://www.ncbi.nlm.nih.gov/pubmed/23295323.
Jackson P, Hougaard KS, Vogel U, Wu D, Casavant L, Williams A, et al. Exposure of pregnant mice to carbon black by intratracheal instillation: toxicogenomic effects in dams and offspring. Mutat Res. 2012;745 1-2:73-83. http://www.ncbi.nlm.nih.gov/pubmed/22001195.
Umezawa M, Onoda A, Korshunova I, Jensen ACO, Koponen IK, Jensen KA, et al. Maternal inhalation of carbon black nanoparticles induces neurodevelopmental changes in mouse offspring. Part Fibre Toxicol. 2018;15 1:36; doi: 10.1186/s12989-018-0272-2. https://www.ncbi.nlm.nih.gov/pubmed/30201004.
Engler-Chiurazzi EB, Stapleton PA, Stalnaker JJ, Ren X, Hu H, Nurkiewicz TR, et al. Impacts of prenatal nanomaterial exposure on male adult Sprague-Dawley rat behavior and cognition. J Toxicol Environ Health A. 2016;79 11:447-52; doi: 10.1080/15287394.2016.1164101. https://www.ncbi.nlm.nih.gov/pubmed/27092594.
Ekvall MT, Lundqvist, M., Kelpsiene, E., Silekis, E., Gunnarsson, S.B., Cedervall, T. Nanoplastics formed during the mechanical breakdown of daily-use polystyrene products. Nanoscale Advances. 2019;1:1055-61.
Kosuth M, Mason SA, Wattenberg EV. Anthropogenic contamination of tap water, beer, and sea salt. PLoS One. 2018;13 4:e0194970; doi: 10.1371/journal.pone.0194970.
Mason SA, Welch VG, Neratko J. Synthetic Polymer Contamination in Bottled Water. Frontiers in chemistry. 2018;6:407; doi: 10.3389/fchem.2018.00407.
Dris R, Gasperi J, Mirande C, Mandin C, Guerrouache M, Langlois V, et al. A first overview of textile fibers, including microplastics, in indoor and outdoor environments. Environ Pollut. 2017;221:453-8; doi: 10.1016/j.envpol.2016.12.013.
Sun X-D, Yuan X-Z, Jia Y, Feng L-J, Zhu F-P, Dong S-S, et al. Differentially charged nanoplastics demonstrate distinct accumulation in Arabidopsis thaliana. Nature nanotechnology. 2020; doi: 10.1038/s41565-020-0707-4. https://doi.org/10.1038/s41565-020-0707-4.

PDF

Journal Publication

published 24 Oct, 2020

Read the published version in Particle and Fibre Toxicology →

Editorial decision: Major Revision
11 Aug, 2020
Review #2 received at journal
08 Aug, 2020
Reviewer #3 agreed at journal
08 Aug, 2020
Review #3 received at journal
08 Aug, 2020
Review #1 received at journal
23 Jul, 2020
Reviewer #2 agreed at journal
20 Jul, 2020
Reviewer #1 agreed at journal
08 Jul, 2020
Reviewers invited by journal
07 Jul, 2020
Editor assigned by journal
03 Jul, 2020
First submitted to journal
02 Jul, 2020
Submission checks completed at journal
02 Jul, 2020
Editor invited by journal
02 Jul, 2020

You are reading this older preprint version

Read the latest preprint version →

Nanopolystyrene Translocation and Fetal Deposition After Acute Lung Exposure During Late-Stage Pregnancy

Status:

Journal Publication

Version 1

Abstract

Figures

Background

Materials And Methods

Results

Litter Characteristics

Fluorescent Optical Imaging

Hyperspectral Darkfield Microscopy

Placental Perfusion

Discussion

Conclusion

Declarations

ACKNOWLEDGEMENTS

FUNDING

CONTRIBUTIONS

ETHICS DECLARATIONS

ETHICS APPROVAL AND CONSENT TO PARTICIPATE

CONSENT FOR PUBLICATION

COMPETING INTERESTS

AVAILABILITY OF DATA AND MATERIALS

References

Status:

Journal Publication

Version 1